Optibrium Revenue and Competitors
Estimated Revenue & Valuation
- Optibrium's estimated annual revenue is currently $11.2M per year.
- Optibrium's estimated revenue per employee is $155,000
Employee Data
- Optibrium has 72 Employees.
- Optibrium grew their employee count by 3% last year.
Optibrium's People
Name | Title | Email/Phone |
---|---|---|
1 | CSO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP Research, BioPharmics Division | Reveal Email/Phone |
4 | Head Sales | Reveal Email/Phone |
5 | Head Brand and Creative | Reveal Email/Phone |
6 | Head Marketing | Reveal Email/Phone |
7 | Director | Reveal Email/Phone |
8 | Director Computational Chemistry | Reveal Email/Phone |
9 | Chief Technology Officer | Reveal Email/Phone |
10 | Director HR | Reveal Email/Phone |
Optibrium Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.3M | 68 | 11% | $3M | N/A |
#2 | $1.4M | 7 | N/A | N/A | N/A |
#3 | $15.7M | 78 | -26% | $176.6M | N/A |
#4 | $39060M | 98035 | 0% | $30 b | $234.4B |
#5 | $130.9M | 651 | N/A | N/A | N/A |
#6 | $25.7M | 161 | N/A | N/A | N/A |
#7 | $124.8M | 910 | 1% | $567.2M | $2.2B |
#8 | $1.2M | 14 | N/A | N/A | N/A |
#9 | $0.9M | 6 | N/A | N/A | N/A |
#10 | $2360M | 4804 | 7% | $22.5M | $10.7B |
#11 | $12.2M | 79 | N/A | N/A | N/A |
#12 | $275.4M | 1554 | 7% | N/A | $4.4B |
#13 | $12.6M | 57 | -15% | N/A | N/A |
#14 | $0.1M | 4 | N/A | N/A | N/A |
#15 | $2.7M | 27 | N/A | N/A | N/A |
#16 | $87.4M | 564 | N/A | N/A | N/A |
#17 | $46.5M | 233 | 2% | $396M | $424.9M |
#18 | $8.4M | 54 | N/A | N/A | N/A |
#19 | $0.5M | 9 | N/A | N/A | N/A |
#20 | $173.8M | 856 | 37% | N/A | N/A |
What Is Optibrium?
N/A
Total Funding
72
Number of Employees
$11.2M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Optibrium News
Pharmaceutical Technology interviewed Chase Smith, PhD, senior application scientist at Optibrium (a software company for drug discovery),...
Optibrium Ltd, a leading developer of software for drug discovery, today announced the release of the latest version of StarDrop,...
Optibrium and BioPharmics enter partnership on computational drug design 20-05-2021 Industry-leading 3D ligand-based design approaches from BioPharmics will be available in StarDrop, Optibrium’s small molecule design and optimisation software. Optibrium Ltd and BioPharmics LLC, leading provid ...
Optibrium and BioPharmics enter partnership on computational drug design 20-05-2021 Industry-leading 3D ligand-based design approaches from BioPharmics will be available in StarDrop, Optibrium’s small molecule design and optimisation software. Optibrium Ltd and BioPharmics LLC, leading provid ...
Optibrium raises investment to advance computer-aided drug discovery 10-02-2021 Investment by Kester Capital will drive commercial growth and the development of new products to improve speed, efficiency, and productivity of the discovery process. Optibrium™, a developer of software for drug d ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.2M | 72 | -43% | N/A |
#2 | $9.1M | 72 | -21% | N/A |
#3 | $11.2M | 72 | 6% | N/A |
#4 | $9.4M | 72 | 13% | N/A |
#5 | $7.5M | 72 | 33% | N/A |